EA201000688A1 - Антагонисты гликозаминогликанов на основе sdf-1 и способы их использования - Google Patents

Антагонисты гликозаминогликанов на основе sdf-1 и способы их использования

Info

Publication number
EA201000688A1
EA201000688A1 EA201000688A EA201000688A EA201000688A1 EA 201000688 A1 EA201000688 A1 EA 201000688A1 EA 201000688 A EA201000688 A EA 201000688A EA 201000688 A EA201000688 A EA 201000688A EA 201000688 A1 EA201000688 A1 EA 201000688A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sdf
methods
antagonists
type
glycosaminoglycans
Prior art date
Application number
EA201000688A
Other languages
English (en)
Russian (ru)
Inventor
Андреас Кунгль
Иза Вернер
Джейсон Слингби
Сими Али
Джон А. Кирби
Original Assignee
Протаффин Биотехнологие Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Протаффин Биотехнологие Аг filed Critical Протаффин Биотехнологие Аг
Publication of EA201000688A1 publication Critical patent/EA201000688A1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/521Chemokines
    • C07K14/522Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EA201000688A 2007-10-24 2008-10-23 Антагонисты гликозаминогликанов на основе sdf-1 и способы их использования EA201000688A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07450189A EP2053060A1 (en) 2007-10-24 2007-10-24 SDF-1-based glyocosaminoglycan antagonists and methods of using same
PCT/EP2008/008960 WO2009053064A1 (en) 2007-10-24 2008-10-23 Sdf-1-based glycosaminoglycan antagonists and methods of using same

Publications (1)

Publication Number Publication Date
EA201000688A1 true EA201000688A1 (ru) 2010-10-29

Family

ID=39133777

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201000688A EA201000688A1 (ru) 2007-10-24 2008-10-23 Антагонисты гликозаминогликанов на основе sdf-1 и способы их использования

Country Status (13)

Country Link
US (1) US20100298203A1 (enExample)
EP (2) EP2053060A1 (enExample)
JP (1) JP2011501675A (enExample)
KR (1) KR20100085041A (enExample)
CN (1) CN101835800A (enExample)
AU (1) AU2008315614A1 (enExample)
BR (1) BRPI0818009A2 (enExample)
CA (1) CA2702502A1 (enExample)
EA (1) EA201000688A1 (enExample)
IL (1) IL205300A0 (enExample)
MX (1) MX2010004025A (enExample)
NZ (1) NZ584278A (enExample)
WO (1) WO2009053064A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2010294225A1 (en) * 2009-09-11 2012-04-05 Protaffin Biotechnologie Ag Composition for treatment of CXCL8-mediated lung inflammation
CN102094043B (zh) * 2010-11-23 2012-11-07 山东农业大学 猪趋化因子cxcl12基因及其应用
EP2686344A1 (en) 2011-03-16 2014-01-22 Protaffin Biotechnologie AG Fgfr1-based antagonists with improved glycosaminoglycan affinity and methods of using same
WO2013007704A2 (en) 2011-07-08 2013-01-17 Protaffin Biotechnologie Ag Novel sdf-1-based glycosaminoglycan antagonist and methods of using same

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364894A (en) * 1993-03-31 1994-11-15 Tremco, Inc. Emulsification of asphalt and modified asphalt with primary emulsifier polymers comprised of acrylic acid type monomers
EP0915969A4 (en) * 1996-04-02 2002-04-17 Progenics Pharm Inc SUPPRESSION OF CD4 + CELL INFECTION BY HIV
JP2003532683A (ja) * 2000-05-09 2003-11-05 ザ ユニバーシティ オブ ブリティッシュ コロンビア 造血細胞のcxcr4アンタゴニスト治療
WO2004094465A2 (en) * 2003-04-23 2004-11-04 The Board Of Trustees Of The University Of Illinois Office Of Technology Management University Of Illinois At Urbana-Champaign Synthetic molecules that mimic chemokines
AT412785B (de) * 2003-12-04 2005-07-25 Kungl Andreas J Dr Gag-bindungsproteine
US7662221B2 (en) * 2006-06-23 2010-02-16 Johns Manville Spray applied building wrap coating material, spray applied building wrap, and building construction assembly
AT504685B1 (de) * 2006-12-20 2009-01-15 Protaffin Biotechnologie Ag Fusionsproteine

Also Published As

Publication number Publication date
KR20100085041A (ko) 2010-07-28
US20100298203A1 (en) 2010-11-25
AU2008315614A1 (en) 2009-04-30
WO2009053064A8 (en) 2009-07-16
CN101835800A (zh) 2010-09-15
NZ584278A (en) 2012-06-29
EP2053060A1 (en) 2009-04-29
EP2203473A1 (en) 2010-07-07
MX2010004025A (es) 2010-04-30
BRPI0818009A2 (pt) 2015-04-14
CA2702502A1 (en) 2009-04-30
JP2011501675A (ja) 2011-01-13
WO2009053064A1 (en) 2009-04-30
IL205300A0 (en) 2010-12-30

Similar Documents

Publication Publication Date Title
CY1118007T1 (el) Μεθοδοι για την χορηγηση υπογλυκαιμικων μεσων
NL301089I2 (nl) imlifidase
MX2010001111A (es) Mutantes mcp-1 que antagonizan glicosaminoglicano y metodos para utilizar los mismos.
TW200716646A (en) (S)-N-methylnaltrexone
EA200971077A1 (ru) Гетероциклические модуляторы киназы
CY1122476T1 (el) Βελτιστοποιημενα μονοκλωνικα αντισωματα εναντι του αναστολεα της οδου του ιστικου παραγοντα (τfρι)
NZ591098A (en) Engineered anti-il-13 antibodies, compositions, methods and uses
UA90048C2 (ru) Кондиционированная композиция и способ ее получения
BRPI0817154B8 (pt) "método de modificar uma célula de levedura para a produção de etanol, célula de levedura modificada, uso de uma célula de levedura modificada e método para a produção de etanol"
EP4400172A3 (en) Piperidin-4-yl azetidine derivatives as jak1 inhibitors
EA200802182A1 (ru) Модифицированные гуманизированные антитела против интерлейкина-18
EA201000006A1 (ru) Способы и композиции для лечения аллергических заболеваний
EA200602243A1 (ru) 3-аминоциклопентанкарбоксамиды в качестве модуляторов хемокиновых рецепторов
EA201071057A1 (ru) Производные азетидина и циклобутана как ингибиторы jak-киназ
NO20091413L (no) WNT-antagonister og deres anvendelse i diagnostiseringen og behandlingen av WNT-medierte forstyrrelser
EA200970403A1 (ru) Бициклические триазолы в качестве модуляторов протеинкиназы
IL183160A0 (en) Indazole-carboxamide compounds
MY191407A (en) Certain chemical entities, compositions and methods
EA201270528A1 (ru) Композиции цитокинов семейства il-17 и их применение
TW200833692A (en) Triazolopyridazine protein kinase modulators
SG178976A1 (en) High affinity human antibodies to human protease-activated receptor-2
EA201290069A1 (ru) Модифицированные полипептиды фактора ix и их применения
MX2010000098A (es) Derivados de guanina policiclicos y sus metodos de uso.
ATE489371T1 (de) Benzamidglucokinaseaktivatoren
EA201190209A1 (ru) Соединения для лечения метаболических расстройств